Table 4.

Relationship between medical specialty (medical oncology vs. others) and percentage of highly important response scores (>3) estimated for each statement through logistic regression analyses

StatementOR95% CL
S1. No mortality effect.0.890.40–1.94
S5. Risk models are difficult1.000.43–2.27
S8. Drugs have no commercial interest1.420.58–3.43
S10. AIs better than SERMs1.490.60–3.68
S4. Unclear who is the appropriate physician1.560.69–3.49
S9. Off label in EU1.570.68–3.62
S6. Lack of medical knowledge1.720.72–4.12
S7. Prevention of curable cancers1.740.73–4.12
S2 Drugs have adverse events1.840.79–4.24
S3. Lack of reliable biomarkers2.420.93–6.25
  • OR, odds ratio adjusted for gender, age at survey, and life expectancy at birth; 95% CL, confidence interval.